Titre (en)
Analysis
2020
Racine
Analysis
2020
Exploration
Accueil
Racine
Racine

Serveur d'exploration Stress et Covid - Analysis (2020)

Index « Titre (en) » - entrée « treatment »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
treating < treatment < treatments  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 21.
[0-20] [0 - 20][0 - 21][20-20][20-40]
Ident.Authors (with country if any)Title
000008 (2020) George Zaki Ghali [États-Unis] ; Michael George Zaki Ghali [États-Unis, Suède]β adrenergic receptor modulated signaling in glioma models: promoting β adrenergic receptor-β arrestin scaffold-mediated activation of extracellular-regulated kinase 1/2 may prove to be a panacea in the treatment of intracranial and spinal malignancy and extra-neuraxial carcinoma
000042 (2020) Qian-Yi Peng ; Xiao-Ting Wang [République populaire de Chine] ; Li-Na ZhangUsing echocardiography to guide the treatment of novel coronavirus pneumonia
000092 (2020) Kenneth Maiese [États-Unis]The mechanistic target of rapamycin (mTOR): Novel Considerations as an Antiviral Treatment and Possibilities for COVID-19.
000147 (2020) Jonathan R. Erlich [Australie] ; Eunice E. To [Australie] ; Stella Liong [Australie] ; Robert Brooks [Australie] ; Ross Vlahos [Australie] ; John J. O'Leary [Australie] ; Doug A. Brooks [Australie] ; Stavros Selemidis [Australie]Targeting Evolutionary Conserved Oxidative Stress and Immunometabolic Pathways for the Treatment of Respiratory Infectious Diseases.
000217 (2020) Jesse H. Wright [États-Unis] ; Robert Caudill [États-Unis]Remote Treatment Delivery in Response to the COVID-19 Pandemic
000256 (2020) Nuo-Ya Zhou [République populaire de Chine] ; Liu Yang [République populaire de Chine] ; Li-Yun Dong [République populaire de Chine] ; Yan Li [République populaire de Chine] ; Xiang-Jie An [République populaire de Chine] ; Jing Yang [République populaire de Chine] ; Liu Yang [République populaire de Chine] ; Chang-Zheng Huang [République populaire de Chine] ; Juan Tao [République populaire de Chine]Prevention and Treatment of Skin Damage Caused by Personal Protective Equipment: Experience of the First-Line Clinicians Treating 2019-nCoV Infection
000272 (2020) Andrea T. Obi ; Geoff D. Barnes ; Thomas W. Wakefield ; Sandra Brown Rvt ; Jonathon L. Eliason ; Erika Arndt ; Peter K. HenkePractical diagnosis and treatment of suspected venous thromboembolism during COVID-19 Pandemic
000314 (2020) Samad Ghaffari [Iran] ; Neda Roshanravan [Iran] ; Helda Tutunchi [Iran] ; Alireza Ostadrahimi [Iran] ; Mahboub Pouraghaei [Iran] ; Behnam Kafil [Iran]Oleoylethanolamide, A Bioactive Lipid Amide, as A Promising Treatment Strategy for Coronavirus/COVID-19
000384 (2020) Petru Ifteni [Roumanie] ; Lorena Dima [Roumanie] ; Andreea Teodorescu [Roumanie]Long-acting injectable antipsychotics treatment during COVID-19 pandemic – A new challenge
000425 (2020) Wolf Schweitzer [Suisse] ; Thomas Ruder [Suisse] ; Rilana Baumeister [Suisse] ; Stephan Bolliger [Suisse] ; Michael Thali [Suisse] ; Eva Meixner [Suisse] ; Garyfalia Ampanozi [Suisse]Implications for forensic death investigations from first Swiss post-mortem CT in a case of non-hospital treatment with COVID-19
000484 (2020) Ondrej Hrusak ; Tomas Kalina ; Joshua Wolf [États-Unis] ; Adriana Balduzzi [Italie] ; Massimo Provenzi [Italie] ; Carmelo Rizzari ; Susana Rives [Espagne] ; María Del Pozo Carlavilla [Espagne] ; Maria Eli Valerio Alonso [Espagne] ; Nerea Domínguez Pinilla [Espagne] ; Jean-Pierre Bourquin [Suisse] ; Kjeld Schmiegelow [Danemark] ; Andishe Attarbaschi [Autriche] ; Pernilla Grillner [Suède] ; Karin Mellgren [Suède] ; J. Ten Bosch Van Der Werff [Belgique] ; Rob Pieters [Pays-Bas] ; Triantafyllia Brozou ; Arndt Borkhardt ; Gabriele Escherich [Allemagne] ; Melchior Lauten [Allemagne] ; Martin Stanulla [Allemagne] ; Owen Smith [Irlande (pays)] ; Allen Eng Juh Yeoh [Singapour] ; Sarah Elitzur ; Ajay Vora [Royaume-Uni] ; Chi-Kong Li [Hong Kong] ; Hany Ariffin [Malaisie] ; Alexandra Kolenova [Slovaquie] ; Luciano Dallapozza [Australie] ; Roula Farah [Liban] ; Jelena Lazic [Serbie] ; Atsushi Manabe [Japon] ; Jan Styczynski [Pologne] ; Gabor Kovacs [Hongrie] ; Gabor Ottoffy [Hongrie] ; Marisa Felice [Argentine] ; Barbara Buldini [Italie] ; Valentino Conter [Italie] ; Jan Stary ; Martin Schrappe [Allemagne]Flash Survey on SARS-CoV-2 Infections in Pediatric Patients on anti-Cancer Treatment
000611 (2020) Emilio A. Herrera ; Alejandro Gonzalez-CandiaComment on Melatonin as a potential adjuvant treatment for COVID-19
000614 (2020) Sandro G. Viveiros Rosa [Brésil] ; Wilson C. Santos [Brésil]Clinical trials on drug repositioning for COVID-19 treatment
000634 (2020) Jaegyun Lim [Corée du Sud] ; Seunghyun Jeon [Corée du Sud] ; Hyun-Young Shin [Corée du Sud] ; Moon Jung Kim [Corée du Sud] ; Yu Min Seong [Corée du Sud] ; Wang Jun Lee [Corée du Sud] ; Kang-Won Choe [Corée du Sud] ; Yu Min Kang [Corée du Sud] ; Baeckseung Lee [Corée du Sud] ; Sang-Joon Park [Corée du Sud]Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by Quantitative RT-PCR
000640 (2020) Yu Kang [États-Unis] ; Tiffany Chen [États-Unis] ; David Mui [États-Unis] ; Victor Ferrari [États-Unis] ; Dinesh Jagasia [États-Unis] ; Marielle Scherrer-Crosbie [États-Unis] ; Yucheng Chen [République populaire de Chine] ; Yuchi Han [États-Unis]Cardiovascular manifestations and treatment considerations in covid-19.
000661 (2020) Rui Zhang [République populaire de Chine] ; Xuebin Wang [République populaire de Chine] ; Leng Ni [République populaire de Chine] ; Xiao Di [République populaire de Chine] ; Baitao Ma [République populaire de Chine] ; Shuai Niu [République populaire de Chine] ; Changwei Liu [République populaire de Chine] ; Russel J. Reiter [États-Unis]COVID-19: Melatonin as a potential adjuvant treatment
000667 (2020) Imran Ali [Arabie saoudite, Inde] ; Omar M. L. Alharbi [Arabie saoudite]COVID-19: Disease, management, treatment, and social impact
000671 (2020) Thabani Nyoni [États-Unis] ; Moses Okumu [États-Unis]COVID-19-Compliant Strategies for Supporting Treatment Adherence Among People Living with HIV in Sub-Saharan Africa
000752 (2020) Fabrizio Dal Moro [Italie] ; Ugolino Livi [Italie]Any possible role of phosphodiesterase type 5 inhibitors in the treatment of severe COVID19 infections? A lesson from urology
000757 (2020) Gang Li ; Rui Hu ; Xuejiao ZhangAntihypertensive treatment with ACEI/ARB of patients with COVID-19 complicated by hypertension
000824 (2011) Steven L. Batki [États-Unis] ; Kelly M. Canfield [États-Unis] ; Robert Ploutz-Snyder [États-Unis]Psychiatric and Substance Use Disorders among Methadone Maintenance Patients with Chronic Hepatitis C Infection: Effects on Eligibility for Hepatitis C Treatment

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/StressCovidV1/Data/2020/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/Title.i -k "treatment" 

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/Title.i  \
                -Sk "treatment" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    StressCovidV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    Title.i
   |clé=    treatment
}}
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed May 6 16:44:09 2020. Site generation: Sun Mar 28 08:26:57 2021